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ABSTRACT
Objectives Further knowledge about typical hand
osteoarthritis (OA) characteristics is needed for the
development of new classification criteria for hand OA.
Methods In a cross-sectional multi-centre international
study, a convenience sample of patients from primary and
secondary/tertiary care with a physician-based hand OA
diagnosis (n = 128) were compared with controls with hand
complaints due to inflammatory or non-inflammatory
conditions (n = 70). We examined whether self-reported,
clinical, radiographic and laboratory findings were associated
with hand OA using logistic regression analyses.
Discrimination between groups was assessed by calculating
the area under receiver operating curves (AUC).
Results Strong associations with hand OA were observed for
radiographic osteophytes (OR = 1.62, 95% CI 1.40 to 1.88) and
joint space narrowing (JSN) (OR = 1.57, 95% CI 1.36 to 1.82)
in the distal interphalangeal (DIP) joints with excellent
discrimination (AUC = 0.82 for both). For osteophytes and JSN,
we found acceptable discrimination between groups in the
proximal interphalangeal joints (AUC = 0.77 and 0.78,
respectively), but poorer discrimination in the first
carpometacarpal joints (AUC = 0.67 and 0.63, respectively).
Painful DIP joints were associated with hand OA, but were less
able to discriminate between groups (AUC = 0.67). Age and
family history of OA were positively associated with hand OA,
whereas negative associations were found for pain, stiffness
and soft tissue swelling in metacarpophalangeal joints, pain
and marginal erosions in wrists, longer morning stiffness,
inflammatory biomarkers and autoantibodies.
Conclusions Differences in symptoms, clinical findings,
radiographic changes and laboratory tests were found in
patients with hand OA versus controls. Radiographic OA
features, especially in DIP joints, were best suited to
discriminate between groups.
INTRODUCTION
Hand osteoarthritis (OA) is currently being
classified by the 1990 American College of
Rheumatology (ACR) criteria,1 which have
important shortcomings that might prevent
much-needed insight in hand OA patho-
genesis and testing of treatments in clinical
trials. Importantly, the criteria are based on
clinical examination parameters often with
poor reliability without the possibility to
classify hand OA based on radiographs.
Moreover, they define OA as present
almost exclusively based on a combination
of affected joints in the 2nd and 3rd
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What is already known about this study?
► Current hand OA classification criteria are unable to
classify persons with hand OA based on radiographic
findings, and they are hampered by being insensitive
to classify hand OA in the general population.
What does this study add?
► Our study shows that radiographic findings,
especially in the DIP joints, demonstrate better
discrimination between hand OA and controls than
features by clinical examination.
► Among self-reported symptoms, best discrimination
between hand OA and controls was found for pain on
most days the previous 6 weeks in the DIP joints.
How might this impact on clinical practice?
► Identification of typical hand OA features is needed
before new classification criteria can be developed
and tested in decision analytic software.
► Widespread use of new classification criteria will
enable comparisons of disease prevalent and
incidence across observational studies and testing
of treatments in clinical trials.
Osteoarthritis
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fingers and the thumb base. Since the control group
in the development of the criteria mainly consisted of
persons with rheumatoid arthritis (RA), the criteria
are not well suited to classify hand OA in a wider
population with rheumatic and musculoskeletal dis-
eases (RMDs). Mainly severe hand OA will be classi-
fied by the ACR criteria making them insensitive in
the general population. Lastly, all hand OA pheno-
types are lumped together, without taking into con-
sideration that different phenotypes could have
different pathogenesis or treatment.
Research on the natural disease course anddevelopment
of effective treatment options is seriously hampered by the
lack of good classification criteria. For example, compar-
isons of disease incidence and prevalence are difficult.
Since different definitions of hand OA are used in clinical
trials rather than the ACR criteria, it is challenging to per-
form systematic reviews or meta-analyses.2 Members of the
EULAR taskforce for evidence-based recommendations on
hand OA diagnosis ranked the development of new classi-
fication criteria as a top research priority.3
Our aim is to identify features that are associated with
handOA and that can discriminate handOA and controls
in a population with hand complaints as a first step to
develop new classification criteria for hand OA overall
and different hand OA phenotypes.
METHODS
Study design
We collected data on patients with hand complaints from
Europe and North America. Patients were recruited from
primary (2 centres) and secondary/tertiary care (10 cen-
tres). Physicians recruited patients with hand complaints,
which could be due to either hand OA (ranging from
mild to severe) or inflammatory and non-inflammatory
non-traumatic conditions. Strict numbers of patients
within each category were not provided. Patients with
unclear causes of their hand complaints were also
included. The treating physician made the diagnosis.
We aimed for approximately 200 patients in our data
set, a number targeted in previous classification criteria
efforts.4 The data collection was funded by the EULAR.
Hand questionnaires
All patients responded to questions about hand com-
plaints, including symptom duration and duration of
morning stiffness in fingers and thumb base joints. On
four separate hand diagrams, they marked the hand
joints (bilateral 2nd–5th distal interphalangeal (DIP),
1st–5th proximal interphalangeal (PIP), 1st–5th metacar-
pophalangeal (MCP) and thumb base) that had been
painful and stiff during the last 48 hours and on most
days the previous 6 weeks. On a whole-body homunculus,
theymarked the joints (bilateral shoulders, elbows, wrists,
hips, knees, ankles and toes) and spine (neck, upper,
middle and lower back) that had been painful on most
days the previous 6 weeks. All toes in one foot were
regarded as one entity. Surgically modified joints were
marked on the same diagram. They completed the Aus-
tralian/Canadian hand index pain (range 0–20), stiffness
(range 0–4) and function subscales (range 0–36) and the
Functional Index of Hand OA (range 0–30).5 6
The patients self-reported painful locking of fingers,
numbness and tingling in the hands, current/past psor-
iasis, current/past inflammatory bowel disease, and
family history of OA, bony swellings/nodes and psoriasis
in first-degree relatives.
Clinical examination
A physician or nurse examined all hand joints (bilateral
2nd–5th DIP, 1st–5th PIP, 1st–5th MCP and thumb base)
for absence/presence of bony enlargement, pain on pres-
sure and soft tissue swelling.Malalignment was assessed in
the DIP, PIP (>15°) and the thumb base joints (squaring).
Absence/presence of dactylitis (2nd–5th fingers) and
tenosynovitis (2nd–5th fingers and thumb base) were
evaluated bilaterally. On the body homunculus, pain on
pressure (upper and middle back, bilateral shoulders,
elbows, wrists, knees and feet) or movement (neck,
lower back, bilateral hips and ankles) was marked. Body
weight and height were self-reported or measured. The
study personnel had previous experience in joint exam-
ination, but no formal training was performed prior to
the data collection. No reliability data was available.
For each patient recruited into the study, the physicians
were asked: ‘How likely is it that the hand complaints in this
patient are due to handOA’ on a 0–10 scale (0 = ‘not likely’,
10 = ‘very likely’). For scores 0–7, the physician indicated
the cause of complaints on a list with 16 RMDs other than
hand OA (response alternatives: ‘no’, ‘unclear’, ‘yes’).
Hand radiographs
Bilateral hand radiographs obtained at each centre were
de-identified and read centrally by two trained readers
(IKH, FK). The central readers have demonstrated excel-
lent inter-reader reliability in a previous clinical trial.7
Bilateral 2nd–5th DIP, 1st–5th PIP, 1st–5th MCP, 1st car-
pometacarpal (CMC1) and scaphotrapeziotrapezoid
(STT) joints were read according to a modified Kellgren-
Lawrence scale (grade 0–4).8 All joints were read for
osteophytes (grade 0–3) and joint space narrowing
(JSN, grade 0–3), and the DIP and PIP joints were also
read for central erosions.9 The readers counted the num-
ber of joints within three joint groups (PIP, MCP and
wrist) with marginal erosions.10
A trained rheumatologist (MK) adjudicated the scoring
of osteophytes and JSN in joints where one central reader
scored no pathology and the other central reader scored
grade 2–3. Central erosions were adjudicated byMKwhen
the number of DIP or PIP joints with erosions differed by
2 or more. A trained rheumatologist (DvdH) adjudicated
the scoring of marginal erosions if the number of mar-
ginal erosions in the PIP, MCP or wrist joint groups dif-
fered by 2 or more between the central readers.
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We used the average score of the central readers (FK,
IKH), except from cases of adjudication, where the adju-
dicated scores (MK or DvdH) were used.
Laboratory tests
Due to feasibility and costs, blood tests were analysed at local
laboratories for erythrocyte sedimentation rate (ESR),
Creactive protein (CRP), anti-cyclic citrullinated peptide
(anti-CCP) and rheumatoid factor (RF) if considered rele-
vant as part of the clinical routine. ESR and CRP could not
be treated as continuous variables since the lowest possible
measurement differed across laboratories. The values were
dichotomised (ESR≥15 mm/hour and CRP≥5 mg/L,
respectively) based on the highest observed area under
receiver operating curves (AUC) for different cut-off values
in our study population. Due to different cut-off values for
elevated anti-CCP and RF across laboratories, the autoanti-
bodies were dichotomised based on the provided reference
value for each laboratory.
Patient and public involvement
TwoEuropean patient research partners (EG andWS) were
involved in the development of the protocol and the pre-
parations of this manuscript and will also be involved in the
future steps of the development of the classification criteria
sets.
Statistical analyses
Based on the question ‘How likely is it that the hand
complaints in this patient are due to hand OA’, we
divided the patients into three groups: clearly not OA
(score 0–3, ‘control group’), unclear (score 4–6) and
clearly OA (score 7–10, ‘hand OA group’). The control
and hand OA groups were included in further analyses,
whereas the unclear group was excluded from all ana-
lyses. We performed a series of logistic regression analyses
using hand OA versus controls as the outcome, and self-
reported, clinical and imaging data as explanatory vari-
ables. Analyses were done with exclusion ofmissing obser-
vations for the respective variable (available case
analyses). Receiver operating curves were constructed
and AUC was calculated. We defined AUC values of
0.50–0.59, 0.60–0.69, 0.70–0.79 and ≥0.80 as none, poor,
acceptable and excellent discrimination, respectively. Sta-
tistical analyses were performed using IBM SPSS version
25. Pvalues <0.05 were considered statistically significant.
Ethical considerations
Ethical committees in each participating country
approved the study. Each patient received written and
oral information about the study and gave their written
informed consent prior to study entry.
RESULTS
We recruited 224 patients, of whom 70 (31.3%) and 128
(57.1%) were in the control and hand OA groups,
respectively. We excluded 26 (11.6%) patients from ana-
lyses since it was unclear whether their complaints were
due to handOA or not. Most controls (n = 65, 92.9%) and
patients with hand OA (n = 123, 96.1%) were recruited
from secondary/tertiary care (n = 8 and n = 10 different
centers, respectively). The remaining controls and
patients with hand OA were recruited from two primary
care centres. The hand OA group was older and included
more women than the controls. In both groups, the
majority had experienced symptoms in their finger joints
for more than 6 months. Fewer patients had symptoms in
their thumb base (table 1). Online supplementary tables
1–3 provide detailed information about other explana-
tory variables, including the number of missing variables.
Patients in the control group demonstrated a wide range
of RMDs (table 2).
Demographic/clinical variables and self-reported symptoms
Female sex, age, family history of OA and bony enlarge-
ment were positively associated with hand OA, with best
discrimination between hand OA and controls for age
and family history of OA (table 3). Despite psoriasis
being negatively associated with hand OA, it could not
discriminate between groups. No association with hand
OA was found for family history of psoriasis or self-
reported inflammatory bowel disease (data not shown).
Finger joint symptoms lastingmore than 6months were
positively associated with hand OA, using less than
6 weeks as reference. Since a symptom duration of
6 weeks to 6 months was not associated with hand OA,
we dichotomised the variable into ‘6 months or less’
versus ‘more than 6 months’ in subsequent analyses
(table 3). No association with hand OA was found for
symptom duration in the thumb base joints (data not
shown).
Morning stiffness in the fingers of ≥1min was present in
88 (68.8%) of patients with hand OA and 53 (75.7%) of
controls. Most patients with hand OA with morning stiff-
ness reported that it lasted maximum 30 min (n = 70,
79.5%). The duration of the morning stiffness in fingers
and thumb base joints was negatively associated with hand
OAwith better discrimination for the fingers. Positive and
negative associations with hand OA were found for pain
on most days the previous 6 weeks in DIP andMCP joints,
respectively (table 3). Similar results were found for pain-
ful joints during the last 48 hours (although a weakened
association in DIP joints) and stiff joints during the pre-
vious 48 hours and 6 weeks (data not shown).
An inverse association between numbness and handOA
was observed, although not statistically significant (table
3). We found no associations with handOA for tingling or
locking of fingers (data not shown). Self-reported pain in
elbow(s), wrist(s) and toes on most days the previous
6 weeks was negatively associated with hand OA (table
3). No associations with hand OA were found for self-
reported pain or self-reported prostheses of other joints
(data not shown).
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The greatest discrimination between hand OA and con-
trols was mostly found for clinical features in the DIP
joints (table 4). The number of DIP joints with bony
enlargement, pain on pressure and malalignment was
positively associated with hand OA. Positive associations
with hand OA were also found for these clinical features
in the PIP joints (except pain on pressure) and thumb
base joints.
Pain on pressure and soft tissue swelling in the MCP
joints and pain on palpation of the wrist(s) were nega-
tively associated with hand OA (table 4). No associations
with hand OA were found for pain on palpation of other
joints, presence of dactylitis or tenosynovitis (data not
shown).
Radiographic and laboratory features
Radiographic OA features in the DIP joints could better
discriminate hand OA and controls than OA features in
PIP and CMC1 joints (table 5). Osteophytes in the STT
joints were not associated with hand OA and showed no
discriminatory capability (data not shown). For JSN in the
STT joints, the strength of association was slightly weaker
(OR = 1.75, 95% CI 1.16 to 2.65) than for JSN in the
CMC1 joints, whereas the AUC value was similar (0.62,
95% CI 0.53 to 0.70). However, among patients with JSN
in STT joint(s), the majority also demonstrated JSN in
CMC1 joint(s) (47/67, 70.1%).
Marginal erosions in the wrist(s), elevated CRP, ESR,
anti-CCP and RF were negatively associated with handOA
(table 5).
DISCUSSION
In the current multi-centre study, we examined different
self-reported, clinical, radiographic and laboratory fea-
tures and their associations with hand OA and discrimi-
natory abilities, as a first step in the development of new
classification criteria for hand, finger and thumb
base OA.
Female sex and higher age were associated with hand
OA,10 which is in line with previous population-based
studies, showing a higher prevalence of hand OA in
women, and an increasing prevalence with higher age,
especially after the age of 50 years.8 Other RMDs such as
RA and fibromyalgia, which were common among our
controls, also predominantly affect women.11 12 This is
reflected in our results showing that female sex could not
discriminate between hand OA and controls. Our hand
OA group was almost 10 years older than our controls,
Table 1 Clinical characteristics of the study population
Hand OA group (n = 128)
Control group
(n = 70)
Age, mean (SD) years 63.7 (12.1) 54.6 (13.3)
Sex, n (%) women 113 (88.3) 53 (75.7)







► Pain (range: 0–20) 8 (5–12) 8 (3–12)
► Stiffness (range: 0–4) 2 (1–3) 2 (1–3)
► Physical function (range: 0–36) 17 (10–24) 15 (15–25)
FIHOA (range: 0–30)* 7 (3–12) 5 (2–13)
Symptom duration in fingers
► No response/not applicable 12 (9.4) 3 (4.3)
► <6 weeks 2 (1.6) 7 (10.0)
► 6 weeks to 6 months 6 (4.7) 7 (10.0)
► >6 months 108 (84.4) 53 (75.7)
Symptom duration in thumb
base
► No response/not applicable 36 (28.1) 28 (40.0)
► <6 weeks 7 (5.5) 3 (4.3)
► 6 weeks to 6 months 6 (4.7) 5 (7.1)
► >6 months 79 (61.7) 34 (48.6)
*Missing information about body mass index (n = 1), FIHOA (n = 20)
and AUSCAN (n = 7) in the hand OA group. Missing information
about FIHOA (n = 9) and AUSCAN (n = 1) in the control group.
AUSCAN, Australian/Canadian hand index; FIHOA, Function Index
of Hand OA OA, osteoarthritis.
Table 2 Diseases and conditions* that were possible or
definite causes of hand complaints in the control group
(n = 70) in ranked order from most to least prevalent
Cause of complaints, n (%)†
Rheumatoid arthritis 26 (37.1)
Other inflammatory rheumatic disease‡ 17 (24.3)
Fibromyalgia 13 (18.6)
Psoriatic arthritis 9 (12.9)
Tenosynovitis/trigger finger 9 (12.9)
Nerve entrapment (incl. carpal tunnel syndrome) 8 (11.4)
Other causes§ 6 (8.6)
Repetitive strain injury 4 (5.7)
Hemochromatosis 3 (4.3)






Dupuytren’s contracture 1 (1.4)
*The list of 16 prespecified diseases and conditions were given to
the treating physician, who marked the relevant disease(s) and
condition(s) for each patient.
†Several persons had more than one cause of hand complaints,
and the total percentage in the column is therefore exceeding 100.
‡Unspecified arthritis or unknown (n = 10), scleroderma (n = 3),
systemic lupus erythematosus (n = 2), palindromic rheumatoid
arthritis (n = 1), spondyloarthritis (n = 1).
§Unknown (n = 4), hypermobility (n = 1), erysipelas (n = 1).
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and increasing age showed acceptable discrimination
between groups. Whereas the ACR criteria for hand OA
do not include points for either female sex or higher age,1
the ACR criteria for both knee and hip OA include
a criterion of age above 50 years.13 14
Family history of OA was one of the few self-reported
items with acceptable discrimination between the groups.
In addition to age and female sex, hereditary factors are
well-known risk factors for hand OA.15 Several candidate
genes have been identified, each leading to small
increases in the risk of hand OA.16
The observed association between symptom duration
and hand OA reflects the chronicity of hand OA as
a disease. Nevertheless, the majority of both patients
with hand OA and controls had experienced symptoms
for more than 6 months, as reflected by the low AUC
value. Self-reported pain and pain on pressure in DIP
joints were positively associated with hand OA, and
Table 3 Demographic/clinical variables and self-reported






































Duration of morning stiffness, per 15 min:












Number of painful joints on most days the previous 6 weeks:





























*Interpretation of AUC values: 0.50–0.59 = no discrimination,
0.60–0.69 = poor discrimination, 0.70–0.79 = acceptable dis-
crimination, and ≥0.80 = excellent discrimination.
AUC, area under receiver operating curves; DIP, distal interpha-
langeal; MCP, metacarpophalangeal; OA, osteoarthritis; PIP,
proximal interphalangeal.
Table 4 Clinical examination features and their association
with hand OA and discriminatory capacity
OR (95% CI) AUC (95% CI)*
Number of joints with bony enlargement:
















Number of joints with pain on pressure:
















Number of joints with soft tissue swelling:
















Number of joints with malalignment:


















*Interpretation of AUC values: 0.50–0.59 = no discrimination,
0.60–0.69 = poor discrimination, 0.70–0.79 = acceptable discrimi-
nation, and ≥0.80 = excellent discrimination.
AUC, area under receiver operating curves; DIP, distal interpha-
langeal; MCP, metacarpophalangeal; OA, osteoarthritis; PIP, prox-
imal interphalangeal.
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positive associations were also observed for pain on pres-
sure in thumb base joints. The involvement of PIP joints
also in other diseases such as RA led to no significant
associations with hand OA for pain in this joint group
and no discrimination. Due to rather high frequency of
RA and other inflammatory RMDs among our controls,
pain, stiffness and soft tissue swelling in MCP joints and
a long duration of morning stiffness were negatively asso-
ciated with hand OA. In line with these results, the cur-
rent ACR criteria for handOA give 1 point to persons with
fewer than three swollen MCP joints,1 whereas the ACR
criteria for knee OA give 1 point to persons with morning
stiffness less than 30 min.14
Although radiographs are not needed for the diagnosis
of hand OA, unless there is doubt about the clinical
diagnosis,3 conventional radiographs may be useful in
research settings for classification of handOA. In general,
the radiographic features showed better discrimination
than the clinical features. Indeed, the number of DIP
joints with osteophytes and JSN were the only features
with excellent discrimination. In addition to positive asso-
ciations observed for all radiographic features in the DIP
joints and hand OA, associations were also found for
radiographic features in the PIP joints and thumb base
joints. The weaker associations and lower AUC values,
especially in thumb base joints, can be explained by
lower OA prevalent in this joint group in our study popu-
lation leading to lower sensitivity and thus lower AUC
values. No statistically significant association and no dis-
crimination was observed for radiographic features in the
MCP joints, due to lower prevalence of OA in this joint
group.Whereas the hand radiographs were read centrally
by two experienced readers and a third adjudicator if
needed, the clinical examination was performed locally
at each center without specific training or reliability test-
ing. Hence, poorer reliability of the clinical examination
may potentially have affected the results.
No imaging modalities other than radiographs were
included in our data collection. Ultrasound may be
more sensitive to detect osteophytes than radiographs
and clinical examination.17 However, due to more lim-
ited data on the validity of ultrasound, radiographs are
currently the recommended outcome measure for eva-
luation of structural hand OA pathologies.18 Further,
most large population-based OA studies have obtained
hand radiographs of their participants and have not used
ultrasound.8 19 20 MRI is not feasible in large studies due
to high costs. Studies of knees have suggested that MRI
findings of OA are so common as to not distinguish well
between those with OA and those without it,21 and we
suspect the same is true for hand OA.
In contrast to inflammatory RMDs, OA is less often
associated with systemic inflammation. Both elevated
ESR and CRP were negatively associated with hand OA
with similar ability to discriminate between persons with
hand OA and controls. Although ESR is often criticised
for being dependent on age, sex, weight and comorbid-
ities, the ACR clinical and laboratory criteria for knee OA
and the ACR criteria for hip OA include ESR using cut-
offs of less than 45 and less than 20 mm/hour,
respectively.13 14 As expected, we found negative associa-
tions with hand OA for anti-CCP and RF. The extra costs
and the invasive nature of blood tests raise questions
about the usefulness of including laboratory markers in
new classification criteria for hand OA. Biomarkers of
Table 5 Radiographic and laboratory features and their
association with hand OA and discriminatory capacity
OR (95% CI) AUC (95% CI)*
Number of joints with radiographic osteophytes:
















Number of joints with radiographic joint space narrowing:
















Number of joints with radiographic central erosions:








Number of joints with radiographic marginal erosions:































*Interpretation of AUC values: 0.50–0.59 = no discrimination,
0.60–0.69 = poor discrimination, 0.70–0.79 = acceptable dis-
crimination, and ≥0.80 = excellent discrimination.
AUC, area under receiver operating curves; CMC1, first carpome-
tacarpal; CRP, Creactive protein; DIP, distal interphalangeal; ESR,
erythrocyte sedimentation rate; MCP; metacarpophalangeal; OA,
osteoarthritis; PIP, proximal interphalangeal.
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bone or cartilage may ultimately prove useful in classify-
ing hand OA, but would not be feasible currently.
The advantage of the current data collection is the
broad range of hand OA symptoms and disease severity
due to inclusion of patients from both primary and sec-
ondary/tertiary care from multiple countries in two con-
tinents. With the inclusion of persons with non-
inflammatory conditions among our controls, we believe
that our future criteria will be more useful in population-
based studies, where non-inflammatory RMDs predomi-
nate as causes of hand complaints rather than systemic
inflammatory RMDs. Our study population had a diverse
range of conditions in contrast to the control population
that was used in the development of the ACR criteria for
hand OA where all controls, except two (2.0%), had an
inflammatory joint disease.1 Psoriatic arthritis is an impor-
tant differential diagnosis that might be difficult to distin-
guish from hand OA that coexists with psoriasis. Relatively
few patients with psoriatic arthritis were included in the
control group and several patients with hand OA had
psoriasis, which may explain why psoriasis could not well
differentiate between hand OA and controls.
The low AUC values for most features suggest that one
single feature is not enough to classify hand OA, but the
classification criteria should include a set of different
features. In the next step, an expert panel will agree
upon a set of features that will be tested in a decision
analytic software (www.1000minds.com), based on the
results from the current study and expert opinions. In
these exercises, the 1000Minds software will be used to
force experts to choose cases more likely to have OA
based on diagnostic features (ie, criteria) and then the
software will be used to rank the criteria according to
their importance. Based on the results from the current
study, which is solely data-driven, and the results from the
1000Minds exercises, which are based on expert opi-
nions, our final criteria set will be determined.
Our analyses focus on the associations with hand OA
overall. Since the physicians were not asked whether the
patients’ complaints were due to interphalangeal OA or
thumb base OA specifically, we were not able to look at
these phenotypes separately. We are aiming for three
separate criteria sets, including hand OA overall, inter-
phalangeal OA and thumb base OA, and the importance
of the potential criteria identified in these analyses will,
therefore, be studied for the three groups separately in
the next steps.
In conclusion, a comparison of patients with hand
OA and controls was performed as a first step in the
development of classification criteria for hand, finger
and thumb base OA. Patients with hand OA and con-
trols demonstrated differences with regard to symp-
toms, clinical findings, radiographic changes and
laboratory tests results with best discrimination
observed for the radiographic features. Additional
exercises to determine the weight of the different
features are needed before the new classification cri-
teria for hand OA can be launched.
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